3D printing tablets: Predicting printability and drug dissolution from rheological data
2020 (English) In: International Journal of Pharmaceutics, ISSN 0378-5173, E-ISSN 1873-3476, Vol. 590, article id 119868Article in journal (Refereed) Published
Abstract [en]
Rheology is an indispensable tool for formulation development, which when harnessed, can both predict a material’s performance and provide valuable insight regarding the material’s macrostructure. However, rheological characterizations are under-utilized in 3D printing of drug formulations. In this study, viscosity measurements were used to establish a mathematical model for predicting the printability of fused deposition modelling 3D printed tablets (Printlets). The formulations were composed of polycaprolactone (PCL) with different amounts of ciprofloxacin and polyethylene glycol (PEG), and different molecular weights of PEG. With all printing parameters kept constant, both binary and ternary blends were found to extrude at nozzle temperatures of 130, 150 and 170 C. In contrast PCL was unextrudable at 130 and 150 C. Three standard rheological models were applied to the experimental viscosity measurements, which revealed an operating viscosity window of between 100-1000 Pa.s at the apparent shear rate of the nozzle. The drug profile of the printlets were experimentally measured over seven days. As a proof-of-concept, machine learning models were developed to predict the dissolution behaviour from the viscosity measurements. The machine learning models were discovered to accurately predict the dissolution profile, with the highest f 2 similarity score value of 90.9 recorded. Therefore, the study demonstrated that using only the viscosity measurements can be employed for the simultaneous high-throughput screening of formulations that are printable and with the desired release profile.
Place, publisher, year, edition, pages Elsevier, 2020. Vol. 590, article id 119868
Keywords [en]
Three-dimensional printing, 3D Printed drug products, Fused Deposition Modeling (FDM), Oral drug delivery systems, Artificial intelligence, Personalized pharmaceuticals and medicines, Prediction models
National Category
Control Engineering
Research subject Control Engineering
Identifiers URN: urn:nbn:se:ltu:diva-80869 DOI: 10.1016/j.ijpharm.2020.119868 ISI: 000591551800008 PubMedID: 32950668 Scopus ID: 2-s2.0-85091675588 OAI: oai:DiVA.org:ltu-80869 DiVA, id: diva2:1469490
Note Validerad;2020;Nivå 2;2020-09-29 (alebob)
2020-09-222020-09-222020-12-17 Bibliographically approved